Top Tweets for #Analystrating
@ClimeFiHQ has initiated rating coverage on @DeepSkyCorp - a milestone for our Analyst Ratings framework.
#ClimeFi #DeepSky #AnalystRating #CarbonRemoval #CDR #NetZero
@HCWCO upgrades #Realbotix to Buy with a $0.70 target, following strong media presence at #CES2025 and a growing sales pipeline.
Read full report: https://t.co/lrA73UYMDz
🇨🇦 $XBOT 🇺🇸 $XBOTF
$XBOT.V #AnalystRating #AIrobots #AI #robots #robotics #TSXV #OTCQB
Is CRBP planning a BBQ party or a funeral on August 13, 2024?
Source: https://t.co/guFZpAal8h
#AnalystRating #Healthcare #CRBP #InvestmentAdvice #august13 #prediction
Analysts Hunt for Undervalued #Biotech #Stocks - @CitiusPharma (NASDAQ: $CTXR) Jazz Pharmaceuticals (NASDAQ: $JAZZ) @CRISPRTX (NASDAQ: $CRSP) Krystal Biotech (NASDAQ: $KRYS) @JazzPharma @KrystalBiotech
#biotechnology #pharma #analystrating #StocksToTrade #StocksToWatch
July 17, 2024 (https://t.co/dB77uPuQvh Newswire) https://t.co/dB77uPuQvh, a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. (Nasdaq:CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. The Company's diversified pipeline includes two late-stage product candidates.
Looking at the sector, Morningstar reported in June, "Biotech had a strong start to 2024, driven by an uptick in M&A and every indication that interest rates would begin to decline," says Morningstar strategist Karen Andersen. "However, the second quarter has been more mixed for the industry, as rates look to be stabilizing rather than declining, given persistent (but improving) inflation. Higher rates tend to make waiting for uncertain returns on biotech investments less attractive."
"We still see tailwinds for the industry going forward. Smaller-cap names are still targets for acquisitions by bigger biopharma firms, and a wave of acquisitions has continued since late last year, particularly focused on oncology and immunology," she says. "We think obesity acquisitions are likely going forward, as big biopharma can bring development and commercialization expertise to multiple programs in midstage trials at small biotechs. Second, on a more fundamental level, new technologies and launches in new therapeutic areas are poised to boost productivity and drive biotech performance."
This week, EF Hutton initiated coverage of Citius Pharmaceuticals (Nasdaq:CTXR) with a Buy recommendation with a price target of $6.00. Analyst Jason Kolbert sees the stock as low risk - high reward based on their two late stage therapeutics, Mino-Lok and LYMPHIR. He also notes that a planned IPO for LYMPHIR this summer, in addition to an early August PDUFA should be catalysts to unlock value for Citius.
paid for news dissemination
https://t.co/tZAucQaFsE
$EMKR Extreme OverSold.
$MGNX $MVIS $NVTS $FROG $DNA $SVV $LIDR $SRTS $INSG $SOUN
#AnalystRating
Hold Rating Consensus.
#PriceTarget Consensus from multiple analyst post earnings report May 9: $2.00
#OverSold
The RSI is deviating 10 points below the 30 oversold line on the daily and 12 points on the hourly RSI.
#Business
$EMKR fiber optic gyroscopes, quartz micro electromechanical systems, inertial navigation systems, tactical navigation, and naval and amphibious navigation, as well as radar positioning and pointing systems, and battlefield/artillery survey systems #Sensors.
#BalanceSheet
Cash Position: $12M
Credit Line: $7M
Debt: $8.3M Long Term.
#Notes
1.
The Debt Is in Good standings and restructured
2.
and the company is entering the next Quarter with about $14M in cash and a credit line.
3.
Closed a sale of its Chip/Fab business in May 2024 for $3M.
This sale also including off loading liabilities.
4.
$EMKR to be cash flow breakeven on an adjusted basis by the end of the September quarter this year 2024.
$EMKR expects profitability in first half 2025.
エヌビディアのアナリストレーティング推移📈
今年の初めから、Buyが圧倒的に増えてるし、目標株価は700ドル弱に💪
SELL付けてる人を逆に知りたい😂w
外的要因が何もなければ600ドルは射程圏内🎯のはず
#Analystrating #Nvidia $NVDA
⚠️Rolls Royce Shares Jump After Jefferies Cites Several Positive Catalysts
#RR #rollsroyce #stocks #uk #FTSE100 #news #analystrating
https://t.co/n4ygtmobmG
New analyst rating for $LCID. Needham gives a underperform rating. @LucidMotors #Lucid #analystrating
Rating via https://t.co/FFGK5X8cBI
Streaming services are taking a hit after Netflix' shock announcement. 9 Analysts downgrade Netflix stock.
Disney and Roku down as well.
#Netflix #NFLX #analystrating #Ratings #DisneyPlus #roku $NFLX $ROKU $DIS
https://t.co/5UvpyQRiwK
Morningstar ha recentemente aggiornato l’Analyst rating di due fondi azionari su Piazza Affari. Entrambi hanno manager esperti e processi solidi. Vediamo quali sono: https://t.co/UPZyiJc8oK
#Morningstar #AzionariItalia #AnalystRating
Hexo: Canaccord Raises Price Target To $1.25 Following Q1 Results
Via @YounggJustin
$HEXO #potstocks #cannabis #earnings #analystrating #pricetarget #upgrade
https://t.co/loI4KHwteR via @TheDeepDive_ca
Can You Make Money With Penny Stocks? 4 That Analysts Say ‘Buy’
https://t.co/FVcMHJHxtP #pennystocks #stockstobuy #stockstotrade #stockmarket #stocks #analysts #analystrating
BMO: 2020 Is Now A Lost Year For Exhibitors Like Cineplex
$CGX #entertainment #cinema #theatre #finance #stocks #analystrating #pricetarget
https://t.co/RPHIMbFS4B via @TheDeepDive_ca
3 Penny Stocks To Buy Under $1? Here’s What Analysts Think
https://t.co/vF3XwKDF8s #pennystocks #stockstowatch #stockstobuy #analystrating #stockmarket #analysts
3 Penny Stocks To Buy Right Now According To Analysts
https://t.co/en1tkrvraN #Pennystocks #stockstowatch #stockstobuy #stockstotrade #StockMarket #news #analystrating
Village Farms: Raymond James Remains Bullish With Dutch Venture Announcement
Via @YounggJustin
$VFF #potstocks #cannabis #Dutch #analystrating #RaymondJames
https://t.co/AxEyZkg4CO via @TheDeepDive_ca
AMD Stock Jumps 4% on Morgan Stanley Upgrade - Market Realist https://t.co/JNqIDt8rlJ
@MarketRealist #AMD #AMDstock #Morganstanley #Josephmoore #analystrating #marketshare #2020earnings
My final day at @MorningstarInc after a very happy 5.8 years. I will miss my #workfamily very much - a HUGE thanks to all of you for working so hard and being so fun. A special thank you for the AMAZING farewell video message and my #analystrating!!!! Best of luck you fab bunch X
#AnalystRating: Weekly Fund Ratings Update | on the upgrades / downgrades of #funds rated by @MorningstarInc https://t.co/v9X6QXk45E
#AnalystRating: Weekly Fund Ratings Update | on the upgrades / downgrades of #funds rated by @MorningstarInc https://t.co/at4TSY9S7C
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.1M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.2M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.4M followers
KATY PERRY
@katyperry
88.8M followers
Taylor Swift
@taylorswift13
82.6M followers
Lady Gaga
@ladygaga
74.1M followers
Virat Kohli
@imvkohli
71.6M followers
Kim Kardashian
@kimkardashian
70.3M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.5M followers
Neymar Jr
@neymarjr
64.5M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.8M followers
X
@x
60.8M followers